S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SANA Sana Biotechnology Inc

2.42

0.00 (0.00%)

Nov 17 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Sana Biotechnology Charts.

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Sana Biotechnology Charts.

Sana Biotechnology Inc News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
Friday 8 November 2024 (1 week ago) • GlobeNewswire Inc.

Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
Monday 4 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
Wednesday 23 October 2024 (4 weeks ago) • PR Newswire (US)

Form 144 - Report of proposed sale of securities
Monday 21 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 8 October 2024 (1 month ago) • Edgar (US Regulatory)

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
Thursday 3 October 2024 (2 months ago) • PR Newswire (US)

Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
Monday 30 September 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 12 September 2024 (2 months ago) • Edgar (US Regulatory)

Sana Biotechnology to Present at September 2024 Investor Conferences
Thursday 29 August 2024 (3 months ago) • GlobeNewswire Inc.

Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
Monday 26 August 2024 (3 months ago) • GlobeNewswire Inc.

More Sana Biotechnology Inc News Articles

Lancaster Colony

Norwood Financial

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions